Trials / Terminated
TerminatedNCT03537534
Intraurethral Lidocaine After Endourology Procedures
Intraurethral Lidocaine After Endourology Procedure to Improve Dysuria in Anesthetized Patients
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- San Antonio Uniformed Services Health Education Consortium · Federal
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Many urological conditions are diagnosed and treated with the use of endourology procedures. Unfortunately, dysuria is a common patient complaint following these procedures. Intraurethral lidocaine instillation is regularly used prior to office-based endourology procedures to alleviate dysuria, as well as, discomfort during the procedure.. Studies have confirmed that office-based procedures using intraurethral lidocaine have resulted in less patient reported dysuria. Many endourology procedures are done under general anesthesia such as urinary stone treatments or resection of bladder tumors. There is a paucity of data regarding the use of intraurethral lidocaine at the conclusion of these procedures evaluating patient reported dysuria. We have designed a prospective, randomized, placebo controlled trial to evaluate the role of intraurethral lidocaine instillation following endourology procedures in the anesthetized patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine Jet Injector | Applying Lidocaine following endourologic procedure |
| DRUG | Placebos | Applying surgilube following endourologic procedure |
Timeline
- Start date
- 2018-04-15
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2018-05-25
- Last updated
- 2024-02-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03537534. Inclusion in this directory is not an endorsement.